Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 2 , Pages 147-157, April 2009

Pathogenesis of primary adrenal insufficiency

Section of Endocrinology, Institute of Medicine, University of Bergen and Department of Medicine, Haukeland University Hospital, N-5021 Bergen, Norway

Autoimmune Addison's disease is caused by autoreactivity towards the adrenal cortex involving 21-hydroxylase autoantibodies and autoreactive T cells. Autoimmune destruction of the adrenal cortex is triggered by hitherto unknown environmental factors in individuals with genetic susceptibility. Several genes have been identified, of which the major histocompatibility complex haplotypes DR3-DQ2 and DR4-DQ8 are most strongly associated. In addition, other genes also implicated in other autoimmune diseases are linked to Addison's disease, such as cytotoxic T lymphocyte antigen 4 (CTLA-4), protein tyrosine phosphatase non-receptor type 22 (PTPN22), major histocompatibility complex class II transactivator (CIITA), and most recently the C-lectin type gene (CLEC16A). Studies employing T cells in humans and animal models, and the collection of large patient cohorts facilitating genome-wide screening projects, will hopefully improve the understanding of the pathogenesis of the disease in the near future.

Keywords: autoimmunity, adrenal cortex, Addison disease, major histocompatibility complex, autoantibodies, steroid 21-hydroxylase, T-lymphocytes

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1521-690X(08)00102-4

doi:10.1016/j.beem.2008.09.004

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 2 , Pages 147-157, April 2009